- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Ultrastructural analysis of breast cancer patient-derived organoids ; volume:21 ; number:1 ; day:10 ; month:8 ; year:2021 ; pages:1-13 ; date:12.2021
Cancer cell international ; 21, Heft 1 (10.8.2021), 1-13, 12.2021
- Urheber
-
Signati, Lorena
Allevi, Raffaele
Piccotti, Francesca
Albasini, Sara
Villani, Laura
Sevieri, Marta
Bonizzi, Arianna
Corsi, Fabio
Mazzucchelli, Serena
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-021-02135-z
- URN
-
urn:nbn:de:101:1-2021103120231210973734
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Signati, Lorena
- Allevi, Raffaele
- Piccotti, Francesca
- Albasini, Sara
- Villani, Laura
- Sevieri, Marta
- Bonizzi, Arianna
- Corsi, Fabio
- Mazzucchelli, Serena
- SpringerLink (Online service)
Ähnliche Objekte (12)
Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer
Patient-derived response estimates from zero-passage organoids of luminal breast cancer
High-content image analysis of patient-derived organoids
Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer
Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
In vitro drug testing using patient-derived ovarian cancer organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
Modelling of primary ciliary dyskinesia using patient‐derived airway organoids
Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer
Patient-derived response estimates from zero-passage organoids of luminal breast cancer
High-content image analysis of patient-derived organoids
Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer
Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
In vitro drug testing using patient-derived ovarian cancer organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
Modelling of primary ciliary dyskinesia using patient‐derived airway organoids
Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer
Patient-derived response estimates from zero-passage organoids of luminal breast cancer
High-content image analysis of patient-derived organoids
Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer
Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
In vitro drug testing using patient-derived ovarian cancer organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies